IL193319A - מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאה - Google Patents
מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאהInfo
- Publication number
- IL193319A IL193319A IL193319A IL19331908A IL193319A IL 193319 A IL193319 A IL 193319A IL 193319 A IL193319 A IL 193319A IL 19331908 A IL19331908 A IL 19331908A IL 193319 A IL193319 A IL 193319A
- Authority
- IL
- Israel
- Prior art keywords
- use according
- aat
- medicament
- administration
- pulmonary disease
- Prior art date
Links
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 title claims 15
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 title claims 15
- 229940024142 alpha 1-antitrypsin Drugs 0.000 title claims 15
- 208000019693 Lung disease Diseases 0.000 title claims 13
- 230000005713 exacerbation Effects 0.000 title claims 3
- 239000003814 drug Substances 0.000 claims 12
- 238000011374 additional therapy Methods 0.000 claims 3
- 239000000443 aerosol Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 206010014561 Emphysema Diseases 0.000 claims 2
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- 206010010456 Congenital emphysema Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 238000012387 aerosolization Methods 0.000 claims 1
- 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 claims 1
- 239000003957 anion exchange resin Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 238000011861 anti-inflammatory therapy Methods 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 229940124630 bronchodilator Drugs 0.000 claims 1
- 239000000168 bronchodilator agent Substances 0.000 claims 1
- 239000003729 cation exchange resin Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 201000003651 pulmonary sarcoidosis Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000008174 sterile solution Substances 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL193319A IL193319A (he) | 2006-02-09 | 2008-08-07 | מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאה |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77146506P | 2006-02-09 | 2006-02-09 | |
| US77365406P | 2006-02-16 | 2006-02-16 | |
| PCT/IL2007/000181 WO2007091266A2 (en) | 2006-02-09 | 2007-02-08 | Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases |
| IL193319A IL193319A (he) | 2006-02-09 | 2008-08-07 | מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאה |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL193319A0 IL193319A0 (en) | 2011-08-01 |
| IL193319A true IL193319A (he) | 2012-03-29 |
Family
ID=44671833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL193319A IL193319A (he) | 2006-02-09 | 2008-08-07 | מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאה |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL193319A (he) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3585423A4 (en) * | 2017-02-21 | 2020-12-23 | Kamada Ltd. | METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN PULMONARY DISEASES |
-
2008
- 2008-08-07 IL IL193319A patent/IL193319A/he active IP Right Grant
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3585423A4 (en) * | 2017-02-21 | 2020-12-23 | Kamada Ltd. | METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN PULMONARY DISEASES |
| US10960062B2 (en) | 2017-02-21 | 2021-03-30 | Kamada Ltd. | Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases |
| IL268752B1 (he) * | 2017-02-21 | 2023-09-01 | Kamada Ltd | שיטות ושימושים באלפא 1-אנטיטריפסין להתערבות מוקדמת במחלות ריאה |
| IL268752B2 (he) * | 2017-02-21 | 2024-01-01 | Kamada Ltd | שיטות ושימושים באלפא 1-אנטיטריפסין להתערבות מוקדמת במחלות ריאה |
Also Published As
| Publication number | Publication date |
|---|---|
| IL193319A0 (en) | 2011-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008135580A (ru) | Альфа-1-антитрипсин для лечения эпизодов воспаления болезней легких | |
| JP2020023542A (ja) | 肺疾患治療のための肥満細胞安定剤 | |
| JP2008536546A5 (he) | ||
| ES3028423T3 (en) | Norketotifen for use in the treatment of respiratory disorders | |
| AU2012306076A1 (en) | Treating cough and tussive attacks | |
| NZ587561A (en) | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist) | |
| US20100202979A1 (en) | Compositions and methods for treatment of pulmonary diseases and conditions | |
| US20100197694A1 (en) | Compositions and methods for treatment of diseases and conditions with increased vascular permeability | |
| WO2009019598A3 (en) | Inhalation therapy for respiratory disorders | |
| US20130125882A1 (en) | Method and composition for treating asthma and copd | |
| IL193319A (he) | מעכב פרוטאינז אלפא–1 לטיפול בתקופות החמרה של מחלות ריאה | |
| US20070185067A1 (en) | Ciclesonide and glycopyrronium combination | |
| JP2016534122A (ja) | 改善された化学特性を有するアミノグリコシドおよびホスホマイシンの組合せ製剤 | |
| JP2008502699A5 (he) | ||
| IL275328B1 (he) | שיטות להשראת סבילות חיסונית ולהפחתת תגובת נוגדנים נגד תרופות | |
| KR20130140672A (ko) | 기침 치료용 카보네이트 유도체 | |
| CA2188143A1 (en) | Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof | |
| Wu et al. | Pulmonary and nasal anti-inflammatory and anti-allergy inhalation aerosol delivery systems | |
| KR20050094810A (ko) | 로플루미래스트와 ｒ,ｒ-포르모테롤을 포함하는 상승작용성조합물 | |
| Tabachnik et al. | Clinical application of aerosols in pediatrics | |
| Simon et al. | Drug treatment of COPD: controversies about agents and how to deliver them | |
| CN103269585B (zh) | 治疗弹性蛋白酶相关病症的超硫酸化双糖 | |
| Abdelrahim et al. | Inhaled Medications Employed in Critically Ill Patients | |
| US20210338718A1 (en) | Methods for preventing and treating pulmonary inflammation and fibrosis | |
| Bauer et al. | Special Applications of Aerosol Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |